Pinto, Cathy Anne http://orcid.org/0000-0002-7793-1706
Tervonen, Tommi http://orcid.org/0000-0001-7303-500X
Jimenez-Moreno, Cecilia http://orcid.org/0000-0002-0488-9631
Levitan, Bennett http://orcid.org/0000-0001-9069-8446
Soriano GabarrĂ³, Montse http://orcid.org/0000-0002-3825-0182
Girman, Cynthia http://orcid.org/0000-0002-5714-174X
Norquist, Josephine M.
Hauber, Brett http://orcid.org/0000-0003-3129-7268
Article History
Accepted: 8 October 2023
First Online: 12 December 2023
Declarations
:
: There was no funding for this research.
: Cathy Anne Pinto and Josephine M. Norquist are employees of Merck Sharp & Dohme LLC, a subsidiary of Merck & Co., Inc., Rahway, NJ, USA (MSD) and stockholders in Merck & Co., Inc., Rahway, NJ, USA. Cynthia Girman is founder and president of CERobs Consulting, which provides services in real world evidence and clinical outcome assessments to pharmaceutical companies. Brett Hauber is an employee of Pfizer, Inc., New York, NY and a stockholder in Pfizer, Inc. Montse Soriano GabarrĂ³ is an employee of Bayer AG and has stocks at Bayer AG and GlaxoSmithKline. Bennett Levitan is an employee of Janssen Research and Development, LLC. He is a stockholder in Johnson & Johnson and a portfolio that at times includes other pharmaceutical and health care-related companies.
: All authors contributed to the study conception, design, and interpretation of the results, either drafted the final manuscript and/or revised it critically for important intellectual content and read and approved the final manuscript.
: Data are included as supplemental material.
: Not applicable; market research.
: Obtained prior to initiating the survey.
: Obtained prior to initiating the survey.
: Included as supplementary materials.
: Not available.